$CYTK Recent News This tiny biotech company takes the

New Post Public Reply Private Reply Replies (0) Message Board

Jan 19, 2015 at 10:23 AM

$CYTK Recent News

This tiny biotech company takes the real ice bucket challenge 9:14 a.m. Sept. 2, 2014 - Michael Brush
Cytokinetics plunges 60% after Lou Gehrig's disease drug fails test 9:26 a.m. April 25, 2014 - Russ Britt
Cytokinetics's massive stock plunge may be premature, analyst says 5:18 p.m. Sept. 3, 2013 - Russ Britt
Cytokinetics shares plummet after heart drug fails to meet primary goal 9:56 a.m. Sept. 3, 2013 - Russ Britt
6 gut checks before the stock market's opening bell 6:57 a.m. Aug. 14, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 8:00 a.m. July 24, 2013 - Shawn Langlois
Cytokinetics rallies on study publication 11:31 a.m. Sept. 27, 2011 - Val Brickates Kennedy
Cytokinetics sinks 18% in early trading 10:37 a.m. Aug. 8, 2011 - Val Brickates Kennedy
Drug indexes hug the flat line 10:57 a.m. Dec. 13, 2010 - Val Brickates Kennedy
Drug indexes sluggish; Cytokinetics plunges 10:07 a.m. Dec. 13, 2010 - Val Brickates Kennedy
Cytokinetics shares up 5% 9:34 a.m. Dec. 7, 2010 - Nick Godt
Cytokinetics to begin Phase II testing of ALS drug 9:13 a.m. March 11, 2010 - Val Brickates Kennedy
Drug stocks slump; Sequenom jumps on upgrade 1:50 p.m. May 27, 2009 - Val Brickates Kennedy
Cytokinetics appoints Sabry executive chairman 4:27 p.m. Jan. 22, 2007 - Ruth Mantell
Cytokinetics names James Sabry as executive chairman 4:02 p.m. Jan. 22, 2007 - Katherine Hunt
Cytokinetics names Robert Blum as CEO 4:02 p.m. Jan. 22, 2007 - Katherine Hunt
Stem-cell rally as sector moves broadly higher 4:44 p.m. Jan. 4, 2007 - Val Brickates Kennedy
Wednesday's biggest U.S. stock gainers and decliners 5:55 p.m. Jan. 3, 2007 - MarketWatch
Drug stocks mixed; Cytokinetics soars on Amgen deal 4:40 p.m. Jan. 3, 2007 - Val Brickates Kennedy
Cytokinetics, Amgen ink deal to develop heart-failure drugs 11:33 a.m. Jan. 3, 2007 - Val Brickates Kennedy

Jim Cramer's 'Mad Money' Recap: You'll Make More Money Buying Into Panic 8:23 p.m. Jan. 8, 2015 - TheStreet.com
8 Biotechnology Stocks to Buy Now 2:45 a.m. Jan. 7, 2015 - InvestorPlace.com
Cytokinetics (CYTK) Is Weak On High Volume Today 10:09 a.m. Jan. 2, 2015 - TheStreet.com
Cytokinetics (CYTK) Looks Good: Stock Soars 16.1% - Tale of the Tape 9:25 a.m. Jan. 2, 2015 - Zacks.com
Mid-Afternoon Market Update: U.S. Stocks Turn Red; Tekmira Pharmaceuticals Shares Climb Following Clinical Study Update 1:17 p.m. Dec. 31, 2014 - benzinga.com
Cytokinetics (CYTK) Stock Rises Today After Roth Capital Increases Price Target 11:44 a.m. Dec. 31, 2014 - TheStreet.com
Mid-Day Gainers From New Year's Eve 2014: NephroGenex And Other Biopharma Stocks 11:42 a.m. Dec. 31, 2014 - benzinga.com
Cytokinetics Surges Amid Roth Capital Raising Its Price Target 10:52 a.m. Dec. 31, 2014 - benzinga.com
Kite Pharma Files IND for Non-Hodgkin Lymphoma Drug - Analyst Blog 5:20 p.m. Dec. 29, 2014 - Zacks.com
Seeking Alpha's Biotech Weekly: AbbVie Slaps Gilead, Achillion's 'Nuc' Power, And More 4:00 p.m. Dec. 26, 2014 - Seeking Alpha
Strong On High Volume: Cytokinetics (CYTK) 10:59 a.m. Dec. 26, 2014 - TheStreet.com
Will Cytokinetics (CYTK) Continue to Surge Higher? - Tale of the Tape 9:50 a.m. Dec. 26, 2014 - Zacks.com
Cytokinetics Rises After Extending Astellas Agreement - Analyst Blog 5:10 p.m. Dec. 24, 2014 - Zacks.com
Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog 2:10 p.m. Dec. 24, 2014 - Zacks.com
Cytokinetics, Incorporated (CYTK) Rises: Stock Jumps 12.6% - Tale of the Tape 9:32 a.m. Dec. 24, 2014 - Zacks.com
Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog 2:30 p.m. Dec. 23, 2014 - Zacks.com
Walgreens Beats Q1 Earnings, Alliance Boots Deal Bears Fruit - Analyst Blog 2:02 p.m. Dec. 23, 2014 - Zacks.com
Cytokinetics, Astellas Continue on Muscle Treatment 9:53 a.m. Dec. 23, 2014 - The Wall Street Journal Interactive Edition
Morning Market Movers 8:54 a.m. Dec. 23, 2014 - benzinga.com
Cytokinetics and Astellas expand partnership 8:28 a.m. Dec. 23, 2014 - Seeking Alpha

Happy New 'Investing' Year: Complementary Reports on Daily Journal, Trina Solar, Cytokinetics, BrainStorm, and Resolute 8:10 a.m. Jan. 2, 2015 - PR Newswire - PRF
Cytokinetics and Astellas Announce Expansion of Collaboration for Development of CK-2127107 in Spinal Muscular Atrophy and Other Neuromuscular Indications 7:30 a.m. Dec. 23, 2014 - Thomson Reuters ONE
Cytokinetics Announces Presentations Relating to Tirasemtiv and Effects on Respiratory Muscle Function at International Symposium on ALS/MND 8:01 a.m. Dec. 5, 2014 - Thomson Reuters ONE
Cytokinetics Announces Presentations Relating to Tirasemtiv at the 25th International Symposium on ALS/MND 4:01 p.m. Dec. 1, 2014 - Thomson Reuters ONE
Cytokinetics to Participate in the 26th Annual Piper Jaffray Healthcare Conference 4:01 p.m. Nov. 26, 2014 - Thomson Reuters ONE
Critical Alerts For Outerwall, Cytokinetics, Union Pacific, Accenture and Monsanto Released By InvestorsObserver 9:31 a.m. Nov. 25, 2014 - PR Newswire - PRF
Cytokinetics' President & CEO Robert Blum Receives 2014 Lou Gehrig Iron Horse Award From ALS Therapy Development Institute 7:31 a.m. Nov. 10, 2014 - Thomson Reuters ONE
Cytokinetics, Incorporated Reports Third Quarter 2014 Financial Results 3:01 p.m. Oct. 30, 2014 - Thomson Reuters ONE
Cytokinetics Provides Development Program Update for Omecamtiv Mecarbil 6:31 a.m. Oct. 27, 2014 - Thomson Reuters ONE
Cytokinetics Provides Development Program Update for Tirasemtiv 6:31 a.m. Oct. 20, 2014 - Thomson Reuters ONE
Cytokinetics to Announce Third Quarter Results on October 30, 2014 4:35 p.m. Oct. 16, 2014 - Thomson Reuters ONE
Cytokinetics Announces Development Program Update for CK-2127107 6:31 a.m. Oct. 13, 2014 - Thomson Reuters ONE
Anacor Pharmaceuticals Appoints Wendell Wierenga to Its Board of Directors 7:30 a.m. Sept. 12, 2014 - BusinessWire - BZX
Cytokinetics to Present at the 34th Annual Canaccord Global Growth Conference 3:01 p.m. Aug. 7, 2014 - Thomson Reuters ONE
Cytokinetics, Incorporated Reports Second Quarter 2014 Financial Results 11:18 p.m. July 30, 2014 - Thomson Reuters ONE
Cytokinetics to Announce Second Quarter Results on July 30, 2014 1:46 a.m. July 17, 2014 - Thomson Reuters ONE
Cytokinetics Announced Additional Results Relating to Tirasemtiv from Pre-Specificed Subgroup Analyses of BENEFIT-ALS 6:31 a.m. July 10, 2014 - Thomson Reuters ONE
Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec 4:55 a.m. July 7, 2014 - PR Newswire - PRF
Cytokinetics Announces Additional Data from BENEFIT-ALS to be Presented at the 13th International Congress on Neuromuscular Diseases 6:32 a.m. July 3, 2014 - Thomson Reuters ONE
Cytokinetics Announces Data Relating to Tirasemtiv Presented at the 2014 Annual Spinal Muscular Atrophy Conference 3:01 p.m. June 13, 2014 - Thomson Reuters ONE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ameritas Hires Actuarial Veteran as VP in Strategic Move

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

2021 Ferrari Portofino Shines Bright at Jake's Motorcars

San Diego might be known for its sunny weather, but Jake's Motorcars just cranked the heat with a 2021 Ferrari Portofino that flaunts a special-ordered Mandarin Orange interior. Now, if that doesn't scream "look at me," I don't know what does. For those who aren't just dabbling in Ferraris but are downright obsessed, let's dig into what makes this sports car not just...

Fidelis Care Opens $120K Workforce Grants for Aid

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

OLX Rolls Out New AI Tools Amid Trust Issues

A Grounded Approach to AI-Driven Market Evolution OLX Group's stepping into some turbulent waters, folks. They've dropped two new AI-assisted tools, Agentic Selling and DealFinder, while users are still trying to wrap their heads around trusting AI. Now, don't get me wrong, there's potential here—but the road ahead isn't paved with gold just yet. AI-Powered Tools Ready...

Atlantic Blvd Apartments: A Game-Changer for Housing

A Bold Move for Attainable Housing Amidst the hustle and bustle of Sterling, Virginia, a new player has hit the scene: Atlantic Blvd Apartments. A property designed solely for attainable housing, this development is a showcase of what can be accomplished when local government and private developers team up with a shared vision. It feels like a breath of fresh air in a...

Psoriasis Shines Spotlight on Stigma in 2026 Campaign

Peeling Back the Layers of Stigma On World Psoriasis Day, we're flipping the script from pity parties to real change. IFPA's 'Look Beyond My Skin' campaign is rallying against the stigma choking young folks with psoriasis. You can't deny the massive size of this issue – over 100 million people wrangle with this condition globally. Yet, as many of these warriors are...

EQS Group Unveils 'Q': AI-Driven Compliance Revolution

Compliance in the Fast Lane The compliance world just got a hefty upgrade with EQS Group's latest rollout: 'Q by EQS,' an AI-powered intelligence layer that's here to shake up the way compliance tasks are handled. It's integrated right into the heart of the EQS Compliance Cockpit, giving teams an edge by automating those pesky, time-sucking routines and guiding them...

EzAccounting: Your Q3 IRS Filing Gets a No-Nonsense Tool

Taking Tax Deadlines Head-On Tax season's got businesses sweating all over the country, but it doesn't have to be a full-scale panic attack if you've got the right gear. That's where ezAccounting steps in, dishing out a reliable solution to hit those looming IRS Form 941 deadlines without a migraine. By November 2, 2026, companies are looking to dodge the bullet of...

Huron Consulting Joins S&P SmallCap 600 Lineup Soon

Shuffling the Deck: Huron Consulting Steps In Just when you thought the index shuffle was settled, along comes an eleventh-hour change. Huron Consulting Group is being welcomed with open arms into the S&P SmallCap 600, booting Supernus Pharmaceuticals to the side. Mark November 3 on your calendars—final scorecards before the trading bell could surprise us all. The S&P...

Innodata Faces Investigation After Major Stock Drop

Rough Waters for Innodata, Stock Takes a Hit The market can be a brutal place when news hits hard, and that's precisely the situation Innodata Inc. (NASDAQ: INOD) found itself in on October 27, 2026. After a promising rally, the company's shares plummeted by over 20% when news broke of a significant workforce reduction overseas. Unpacking the Numbers Behind the Dive The...